High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 Rituximab

被引：0
|
作者：
W. Becker
Th. Behr
机构：
[1] Department of Nuclear Medicine,
[2] University of Göttingen,undefined
[3] Germany,undefined
[4] e-mail: wbecker@med-uni-goettingen.de,undefined
[5] Phone: +49/551/39-8510,undefined
[6] Fax: +49/51/39-8526,undefined
来源：
Annals of Hematology | 2001年 / 80卷 / Suppl 3期
关键词：
Lymphoma; High Dose Radioimmunotherapy;
D O I：
10.1007/PL00022777
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：B130 / B131
相关论文
共 50 条
  • [31] Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma
    Witzig, TE
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (Suppl 1) : S91 - S95
  • [32] Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma
    Thomas E. Witzig
    Cancer Chemotherapy and Pharmacology, 2001, 48 : S91 - S95
  • [33] RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMA
    EARY, JF
    ANNALS OF ONCOLOGY, 1991, 2 : 187 - 190
  • [34] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Kang, Hye Jin
    Lee, Seung-Sook
    Byun, Byung Hyun
    Kim, Kyeong Min
    Lim, Ilhan
    Choi, Chang Woon
    Suh, Cheolwon
    Kim, Won Seog
    Nam, Seung-Hyun
    Lee, Soon Il
    Eom, Hyeon Seok
    Shin, Dong-Yeop
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 945 - 953
  • [35] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Hye Jin Kang
    Seung-Sook Lee
    Byung Hyun Byun
    Kyeong Min Kim
    Ilhan Lim
    Chang Woon Choi
    Cheolwon Suh
    Won Seog Kim
    Seung-Hyun Nam
    Soon Il Lee
    Hyeon Seok Eom
    Dong-Yeop Shin
    Sang Moo Lim
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 945 - 953
  • [36] Combining Low-Dose External Beam With Radioimmunotherapy for Patients With Relapsed/Refractory B-Cell Lymphoma
    Tomblyn, M. B.
    Strom, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S61 - S61
  • [37] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience
    Maren Bienert
    Ingrid Reisinger
    Stefanie Srock
    Beatrice I Humplik
    Christel Reim
    Thomas Kroessin
    Norbert Avril
    Antonio Pezzutto
    Dieter L Munz
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 1225 - 1233
  • [38] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma:: initial experience
    Bienert, M
    Reisinger, I
    Srock, S
    Humplik, BI
    Reim, C
    Kroessin, T
    Avril, N
    Pezzutto, A
    Munz, DL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) : 1225 - 1233
  • [39] Radioimmunotherapy of SCID mice bearing human B-cell lymphoma using I-131 labeled anti-CD20 monoclonal antibody
    Oriuchi, N
    Higuchi, T
    Alyafei, S
    Zhang, H
    Nakasone, Y
    Watanabe, N
    Kanda, H
    Hashimoto, M
    Inoue, T
    Endo, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1213 - 1213
  • [40] Radioimmunotherapy for B-cell lymphoma:: Y90 ibritumomab tiuxetan and I131 tositumomab
    Davies, A. J.
    ONCOGENE, 2007, 26 (25) : 3614 - 3628
12345